Companies / Xilio Therapeutics, Inc. / Activity
Activity — Xilio Therapeutics, Inc.
2 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jan 2, 2026 | Brennan Kevin M. Executive | Sell | Common Stock | $1.2K | -2K -22.28% | 6,371 0.11% of shares | low |
| Jan 2, 2026 | Frankenfield Christopher James Executive | Sell | Common Stock | $4.5K | -7K -22.11% | 24,766 0.43% of shares | low |